- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT00958698
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NURSE-DELIVERED WRITE SYMPTOMS vs. SELF-DIRECTED WRITE SYMPTOMS vs. CARE AS USUAL FOR OPTIMAL SYMPTOM MANAGEMENT FOR WOMEN WITH RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER
Przegląd badań
Status
Szczegółowy opis
PRIMARY OBJECTIVE:
I. Compare the efficacy of nurse-delivered WRITE Symptoms? and self-directed WRITE Symptoms? vs usual care interventions in improving target symptom representations (i.e., decreases in symptom severity, symptom-related distress, and symptom consequences as measured by the Symptom Representation Questionnaire [SRQ]) in patients with recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer.
SECONDARY OBJECTIVES:
I. Compare the efficacy of nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions in improving target symptom representations in these patients at 4 weeks.
II. Compare the efficacy of nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions in improving target symptom controllability in these patients at 4, 8, and 12 weeks.
III. Compare the efficacy of nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions in improving indicators of quality of life (QOL) of these patients as measured by the FACT-O and the CES-Depression inventory short form at 4, 8, and 12 weeks.
IV. Compare the efficacy of nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions in improving communication with health care providers about symptoms, implementation of new symptom management strategies (health care provider recommended as well as patient-initiated changes), and perceived effectiveness of strategies (health care provider recommended as well as patient-initiated changes) in these patients at 4, 8, and 12 weeks.
V. Compare the efficacy of nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions in improving patient-related barriers to symptom management as measured by the Symptom Management Barriers Questionnaire at 4, 8, and 12 weeks.
EXPLORATORY OBJECTIVES:
I. Compare trajectories of change for overall symptom severity in patients undergoing nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions using monthly assessments to explore potential long-term effects of the WRITE Symptoms? interventions.
II. Compare trajectories of change for QOL of patients undergoing nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions using monthly assessments to explore potential long-term effects of the WRITE Symptoms? interventions.
III. Compare trajectories of change for symptom severity, distress, communication, and implementation of new strategies for non-targeted symptoms in patients undergoing nurse-delivered WRITE Symptoms? vs self-directed WRITE Symptoms? vs usual care interventions using monthly assessments to explore whether patients are able to generalize the symptom management approaches taught in WRITE Symptoms? interventions to their other non-targeted symptoms.
IV. Explore whether changes in symptom representations mediate changes in QOL of these patients at 8 and 12 weeks.
V. Explore whether effects of the WRITE Symptoms? interventions on primary and secondary endpoints at 8 and 12 weeks differ based on the following patient characteristics assessed at baseline: age, education, and ethnicity; depression as measured by the CES-D short form; trait anxiety as measured by the STAI; optimism as measured by the LOT-R; social support as measured by the ISEL; and symptom severity as measured by the SRQ.
OUTLINE: This is a multicenter study. Patients are stratified according to race/ethnicity (non-Hispanic white vs Hispanic or non-white). Patients are randomized to 1 of 3 intervention arms.
ARM I (nurse-delivered intervention): Patients are given password-protected access to their own web-based message board to communicate with a research nurse. The nurse leads the patient through the WRITE Symptoms? intervention module comprising representational assessment; exploring concerns/misconceptions/gaps/confusions; creating conditions for conceptual change; introducing new information, goal setting, and development of a symptom management plan; and summary via asynchronous postings to the patient's message board. Patients work through 3 selected symptoms using the nurse-delivered WRITE Symptoms? intervention module over approximately 4 weeks. Two weeks later, the patient's symptom management strategy and their desire to make further changes are evaluated by additional interaction with the nurse via the message board. The nurse will encourage the patient to try new selected strategies, continue with effective strategies, and work with local health care providers in an ongoing process to improve symptom management. Patients are given access to a resource guide that includes self-care guides for 26 symptoms. They are encouraged to use the same process taught for their 3 selected symptoms for any other symptoms that arise after the course of the intervention.
ARM II (self-directed intervention): Patients are given password-protected access to an interactive web-based computer program that will lead them through a modified WRITE Symptoms? intervention module (comprising the same elements as in arm I) without guidance and individualized recommendations from a nurse. Patients work through 3 selected symptoms using the WRITE Symptoms? intervention module over approximately 4 weeks. Two weeks later, patients are prompted by the computer program to respond to questions about their symptom management strategy and their desire to make further changes. The program will generate an encouragement for the patient to try new selected strategies, continue with effective strategies, and continue the new approach to symptom management with local health care providers in an ongoing process to improve symptom management. Patients are given access to a resource guide that includes self-care guides for 26 symptoms. They are encouraged to use the same process taught for their 3 selected symptoms for any other symptoms that arise after the course of the intervention.
ARM III (usual care): Patients are given password-protected access to online questionnaires. Patients are prompted monthly to complete online questionnaires. Patients receive standard symptom management from their local health care providers.
In all arms, patients complete online questionnaires to assess outcome measures at baseline, at 4, 8, and 12 weeks, and then every 4 weeks for 1 year.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Arizona
-
Phoenix, Arizona, Stany Zjednoczone, 85012
- Gynecologic Oncology Group of Arizona
-
-
California
-
Los Angeles, California, Stany Zjednoczone, 90095
- UCLA / Jonsson Comprehensive Cancer Center
-
Los Angeles, California, Stany Zjednoczone, 90048
- Cedars Sinai Medical Center
-
Mountain View, California, Stany Zjednoczone, 94040
- Palo Alto Medical Foundation-Gynecologic Oncology
-
-
Colorado
-
Aurora, Colorado, Stany Zjednoczone, 80045
- University of Colorado Hospital
-
-
Connecticut
-
Hartford, Connecticut, Stany Zjednoczone, 06102
- Hartford Hospital
-
New Britain, Connecticut, Stany Zjednoczone, 06050
- The Hospital of Central Connecticut
-
-
Hawaii
-
Honolulu, Hawaii, Stany Zjednoczone, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Stany Zjednoczone, 96813
- University of Hawaii Cancer Center
-
Honolulu, Hawaii, Stany Zjednoczone, 96826
- Kapiolani Medical Center for Women and Children
-
-
Illinois
-
Decatur, Illinois, Stany Zjednoczone, 62526
- Decatur Memorial Hospital
-
Springfield, Illinois, Stany Zjednoczone, 62781
- Memorial Medical Center
-
Urbana, Illinois, Stany Zjednoczone, 61801
- Carle Cancer Center
-
-
Indiana
-
Elkhart, Indiana, Stany Zjednoczone, 46515
- Elkhart General Hospital
-
Elkhart, Indiana, Stany Zjednoczone, 46514
- Michiana Hematology Oncology PC-Elkhart
-
Elkhart, Indiana, Stany Zjednoczone, 46514-2098
- Elkhart Clinic
-
Indianapolis, Indiana, Stany Zjednoczone, 46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Kokomo, Indiana, Stany Zjednoczone, 46904
- Community Howard Regional Health
-
La Porte, Indiana, Stany Zjednoczone, 46350
- IU Health La Porte Hospital
-
Mishawaka, Indiana, Stany Zjednoczone, 46545
- Michiana Hematology Oncology PC-Mishawaka
-
Mishawaka, Indiana, Stany Zjednoczone, 46545
- Saint Joseph Regional Medical Center-Mishawaka
-
Plymouth, Indiana, Stany Zjednoczone, 46563
- Michiana Hematology Oncology PC-Plymouth
-
South Bend, Indiana, Stany Zjednoczone, 46601
- Memorial Hospital of South Bend
-
South Bend, Indiana, Stany Zjednoczone, 46601
- Michiana Hematology Oncology PC-South Bend
-
South Bend, Indiana, Stany Zjednoczone, 46628
- Northern Indiana Cancer Research Consortium
-
South Bend, Indiana, Stany Zjednoczone, 46617
- South Bend Clinic
-
Westville, Indiana, Stany Zjednoczone, 46391
- Michiana Hematology Oncology PC-Westville
-
-
Iowa
-
Clive, Iowa, Stany Zjednoczone, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Stany Zjednoczone, 50325
- Medical Oncology and Hematology Associates-West Des Moines
-
Des Moines, Iowa, Stany Zjednoczone, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Stany Zjednoczone, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Stany Zjednoczone, 50309
- Medical Oncology and Hematology Associates-Des Moines
-
Des Moines, Iowa, Stany Zjednoczone, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Stany Zjednoczone, 50309
- Iowa-Wide Oncology Research Coalition NCORP
-
Des Moines, Iowa, Stany Zjednoczone, 50314
- Medical Oncology and Hematology Associates-Laurel
-
Iowa City, Iowa, Stany Zjednoczone, 52242
- University of Iowa/Holden Comprehensive Cancer Center
-
West Des Moines, Iowa, Stany Zjednoczone, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, Stany Zjednoczone, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Kansas City, Kansas, Stany Zjednoczone, 66112
- Providence Medical Center
-
Overland Park, Kansas, Stany Zjednoczone, 66209
- Menorah Medical Center
-
Overland Park, Kansas, Stany Zjednoczone, 66213
- Saint Luke's South Hospital
-
Prairie Village, Kansas, Stany Zjednoczone, 66208
- Kansas City NCI Community Oncology Research Program
-
Shawnee Mission, Kansas, Stany Zjednoczone, 66204
- Shawnee Mission Medical Center-KCCC
-
-
Louisiana
-
Shreveport, Louisiana, Stany Zjednoczone, 71105
- CHRISTUS Highland Medical Center
-
-
Maryland
-
Baltimore, Maryland, Stany Zjednoczone, 21287
- Johns Hopkins University/Sidney Kimmel Cancer Center
-
Bethesda, Maryland, Stany Zjednoczone, 20889-5600
- Walter Reed National Military Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, Stany Zjednoczone, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, Stany Zjednoczone, 02114
- Massachusetts General Hospital Cancer Center
-
Worcester, Massachusetts, Stany Zjednoczone, 01655
- University of Massachusetts Medical School
-
Worcester, Massachusetts, Stany Zjednoczone, 01605
- University of Massachusetts Memorial Health Care
-
-
Michigan
-
Detroit, Michigan, Stany Zjednoczone, 48201
- Wayne State University/Karmanos Cancer Institute
-
Escanaba, Michigan, Stany Zjednoczone, 49829
- Green Bay Oncology - Escanaba
-
Grand Rapids, Michigan, Stany Zjednoczone, 49503
- Spectrum Health at Butterworth Campus
-
Iron Mountain, Michigan, Stany Zjednoczone, 49801
- Green Bay Oncology - Iron Mountain
-
Kalamazoo, Michigan, Stany Zjednoczone, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Stany Zjednoczone, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Stany Zjednoczone, 49048
- Borgess Medical Center
-
Niles, Michigan, Stany Zjednoczone, 49120
- Lakeland Hospital Niles
-
Royal Oak, Michigan, Stany Zjednoczone, 48073
- William Beaumont Hospital-Royal Oak
-
Saint Joseph, Michigan, Stany Zjednoczone, 49085
- Lakeland Medical Center Saint Joseph
-
Saint Joseph, Michigan, Stany Zjednoczone, 49085
- Marie Yeager Cancer Center
-
-
Minnesota
-
Burnsville, Minnesota, Stany Zjednoczone, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, Stany Zjednoczone, 55433
- Mercy Hospital
-
Edina, Minnesota, Stany Zjednoczone, 55435
- Fairview-Southdale Hospital
-
Fridley, Minnesota, Stany Zjednoczone, 55432
- Unity Hospital
-
Hutchinson, Minnesota, Stany Zjednoczone, 55350
- Hutchinson Area Health Care
-
Maplewood, Minnesota, Stany Zjednoczone, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Stany Zjednoczone, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Stany Zjednoczone, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Stany Zjednoczone, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, Stany Zjednoczone, 55455
- University of Minnesota/Masonic Cancer Center
-
New Ulm, Minnesota, Stany Zjednoczone, 56073
- New Ulm Medical Center
-
Robbinsdale, Minnesota, Stany Zjednoczone, 55422
- North Memorial Medical Health Center
-
Saint Louis Park, Minnesota, Stany Zjednoczone, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park, Minnesota, Stany Zjednoczone, 55416
- Metro Minnesota Community Oncology Research Consortium
-
Saint Paul, Minnesota, Stany Zjednoczone, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Stany Zjednoczone, 55102
- United Hospital
-
Shakopee, Minnesota, Stany Zjednoczone, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Stany Zjednoczone, 55082
- Lakeview Hospital
-
Waconia, Minnesota, Stany Zjednoczone, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Stany Zjednoczone, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Stany Zjednoczone, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
-
Missouri
-
Kansas City, Missouri, Stany Zjednoczone, 64116
- North Kansas City Hospital
-
Kansas City, Missouri, Stany Zjednoczone, 64111
- Saint Luke's Hospital of Kansas City
-
Kansas City, Missouri, Stany Zjednoczone, 64132
- Research Medical Center
-
Kansas City, Missouri, Stany Zjednoczone, 64108
- Truman Medical Center
-
Kansas City, Missouri, Stany Zjednoczone, 64118
- Heartland Hematology and Oncology Associates Incorporated
-
Kansas City, Missouri, Stany Zjednoczone, 64114
- Saint Joseph Health Center
-
Lee's Summit, Missouri, Stany Zjednoczone, 64086
- Saint Luke's East - Lee's Summit
-
Liberty, Missouri, Stany Zjednoczone, 64068
- Liberty Radiation Oncology Center
-
Saint Joseph, Missouri, Stany Zjednoczone, 64507
- Saint Joseph Oncology Inc
-
Saint Joseph, Missouri, Stany Zjednoczone, 64507
- Heartland Regional Medical Center
-
Saint Louis, Missouri, Stany Zjednoczone, 63110
- Washington University School of Medicine
-
Springfield, Missouri, Stany Zjednoczone, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Stany Zjednoczone, 65804
- Mercy Hospital Springfield
-
-
Montana
-
Billings, Montana, Stany Zjednoczone, 59101
- Billings Clinic Cancer Center
-
-
Nebraska
-
Omaha, Nebraska, Stany Zjednoczone, 68114
- Nebraska Methodist Hospital
-
Omaha, Nebraska, Stany Zjednoczone, 68198
- University of Nebraska Medical Center
-
-
New Mexico
-
Albuquerque, New Mexico, Stany Zjednoczone, 87102
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, Stany Zjednoczone, 87106
- Southwest Gynecologic Oncology Associates Inc
-
Las Cruces, New Mexico, Stany Zjednoczone, 88011
- Memorial Medical Center - Las Cruces
-
-
New York
-
Brightwaters, New York, Stany Zjednoczone, 11718
- Island Gynecologic Oncology
-
-
Ohio
-
Akron, Ohio, Stany Zjednoczone, 44307
- Cleveland Clinic Akron General
-
Akron, Ohio, Stany Zjednoczone, 44304
- Summa Akron City Hospital/Cooper Cancer Center
-
Cleveland, Ohio, Stany Zjednoczone, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Stany Zjednoczone, 44109
- MetroHealth Medical Center
-
Cleveland, Ohio, Stany Zjednoczone, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, Stany Zjednoczone, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, Stany Zjednoczone, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Stany Zjednoczone, 43210
- Ohio State University Comprehensive Cancer Center
-
Dayton, Ohio, Stany Zjednoczone, 45409
- Miami Valley Hospital
-
Mayfield Heights, Ohio, Stany Zjednoczone, 44124
- Hillcrest Hospital Cancer Center
-
Mentor, Ohio, Stany Zjednoczone, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Stany Zjednoczone, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Stany Zjednoczone, 74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
-
Pennsylvania
-
Abington, Pennsylvania, Stany Zjednoczone, 19001
- Abington Memorial Hospital
-
Allentown, Pennsylvania, Stany Zjednoczone, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Bryn Mawr, Pennsylvania, Stany Zjednoczone, 19010
- Bryn Mawr Hospital
-
Paoli, Pennsylvania, Stany Zjednoczone, 19301
- Paoli Memorial Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15224
- West Penn Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15213
- UPMC-Magee Womens Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15232
- University of Pittsburgh Cancer Institute (UPCI)
-
Wynnewood, Pennsylvania, Stany Zjednoczone, 19096
- Lankenau Medical Center
-
Wynnewood, Pennsylvania, Stany Zjednoczone, 19096
- Main Line Health NCORP
-
-
Rhode Island
-
Providence, Rhode Island, Stany Zjednoczone, 02905
- Women and Infants Hospital
-
-
South Carolina
-
Charleston, South Carolina, Stany Zjednoczone, 29425
- Medical University of South Carolina
-
-
Texas
-
Houston, Texas, Stany Zjednoczone, 77030
- The Methodist Hospital System
-
-
Virginia
-
Richmond, Virginia, Stany Zjednoczone, 23298
- Virginia Commonwealth University/Massey Cancer Center
-
-
Wisconsin
-
Eau Claire, Wisconsin, Stany Zjednoczone, 54701
- Marshfield Clinic Cancer Center at Sacred Heart
-
Green Bay, Wisconsin, Stany Zjednoczone, 54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay, Wisconsin, Stany Zjednoczone, 54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Green Bay, Wisconsin, Stany Zjednoczone, 54303
- Green Bay Oncology Limited at Saint Mary's Hospital
-
Green Bay, Wisconsin, Stany Zjednoczone, 54301-3526
- Green Bay Oncology at Saint Vincent Hospital
-
Madison, Wisconsin, Stany Zjednoczone, 53792
- University of Wisconsin Hospital and Clinics
-
Manitowoc, Wisconsin, Stany Zjednoczone, 54221
- Holy Family Memorial Hospital
-
Marinette, Wisconsin, Stany Zjednoczone, 54143
- Bay Area Medical Center
-
Marshfield, Wisconsin, Stany Zjednoczone, 54449
- Marshfield Medical Center-Marshfield
-
Milwaukee, Wisconsin, Stany Zjednoczone, 53215
- Aurora Saint Luke's Medical Center
-
Minocqua, Wisconsin, Stany Zjednoczone, 54548
- Marshfield Clinic-Minocqua Center
-
Oconto Falls, Wisconsin, Stany Zjednoczone, 54154
- Saint Vincent Hospital Cancer Center at Oconto Falls
-
Rice Lake, Wisconsin, Stany Zjednoczone, 54868
- Marshfield Medical Center-Rice Lake
-
Sturgeon Bay, Wisconsin, Stany Zjednoczone, 54235
- Green Bay Oncology - Sturgeon Bay
-
West Allis, Wisconsin, Stany Zjednoczone, 53227
- Aurora West Allis Medical Center
-
Weston, Wisconsin, Stany Zjednoczone, 54476
- Marshfield Clinic - Weston Center
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
Diagnosis of ovarian, fallopian tube, or primary peritoneal cancer that has recurred or persisted following primary therapy
- Active disease or current treatment are not required
Must be experiencing ? 3 symptoms associated with ovarian cancer or cancer treatment, including, but not limited to, any of the following:
- Abdominal bloating or cramping
- Nausea, vomiting, or diarrhea
- Constipation
- Anorexia
- Anxiety
- Depression
- Dizziness
- Drowsiness
- Dry mouth
- Fatigue
- Headaches
- Hair loss
- Hot flashes
- Memory concerns
- Mood swings
- Mouth sores
- Pain
- Peripheral neuropathies
- Sexuality concerns
- Sleep disturbances
- Shortness of breath
- Skin rash or palmar-plantar erythrodysesthesia
- Urinary problems
- Weight gain or loss
- GOG performance status 0-2
- Able to read and write English
- Access to computer and the Internet required
- Concurrent treatment on other clinical trials allowed
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie podtrzymujące
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Arm I (nurse-assisted intervention module)
Patients are given password-protected access to their own web-based message board to communicate with a research nurse.
The nurse leads patients through WRITE Symptoms?
intervention module, with personalized support and advice.
The nurse will encourage the patient to try new selected strategies, continue with effective strategies, and work with local health care providers in an ongoing process to improve symptom management.
|
Badania pomocnicze
Inne nazwy:
Badania pomocnicze
Badania pomocnicze
Inne nazwy:
Ancillary studies
Ancillary studies
Inne nazwy:
Ancillary studies
|
|
Eksperymentalny: Arm II (self-directed intervention module)
Patients are given password-protected access to an interactive web-based computer program that will lead them through a modified WRITE Symptoms?
intervention module (comprising the same elements as in arm I) without guidance and individualized recommendations from a nurse.
Patients work through 3 selected symptoms using the WRITE Symptoms?
intervention module over approximately 4 weeks.
The program will generate an encouragement for the patient to try new selected strategies, continue with effective strategies, and continue the new approach to symptom management with local health care providers in an ongoing process to improve symptom management.
|
Badania pomocnicze
Inne nazwy:
Badania pomocnicze
Badania pomocnicze
Inne nazwy:
Ancillary studies
Inne nazwy:
Ancillary studies
|
|
Aktywny komparator: Arm III (standard care from local provider)
Patients are given password-protected access to online questionnaires.
Patients are prompted monthly to complete online questionnaires.
Patients receive standard symptom management from their local health care providers.
|
Badania pomocnicze
Inne nazwy:
Badania pomocnicze
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Ramy czasowe |
|---|---|
|
Symptom severity, symptom-related distress, consequences, and control of symptoms as measured by the Symptom Representation Questionnaire
Ramy czasowe: Baseline and at 4, 8, and 12 weeks
|
Baseline and at 4, 8, and 12 weeks
|
Miary wyników drugorzędnych
Miara wyniku |
Ramy czasowe |
|---|---|
|
Health-related quality of life as measured by the FACT-O
Ramy czasowe: Baseline and at 4, 8, and 12 weeks, and every 4 weeks for 1 year
|
Baseline and at 4, 8, and 12 weeks, and every 4 weeks for 1 year
|
|
Depressive symptoms as measured by the CES-D short form
Ramy czasowe: Baseline and at 4, 8, and 12 weeks, and every 4 weeks for 1 year
|
Baseline and at 4, 8, and 12 weeks, and every 4 weeks for 1 year
|
|
Communication with health care providers and use of self-care strategies assessed by investigator-developed survey
Ramy czasowe: Baseline and at 4, 8, and 12 weeks
|
Baseline and at 4, 8, and 12 weeks
|
|
Implementation and perceived effectiveness of new symptom management strategies assessed by questionnaire
Ramy czasowe: Baseline and at 4, 8, and 12 weeks
|
Baseline and at 4, 8, and 12 weeks
|
|
Barriers to symptom management as measured by the Symptom Management Barriers Questionnaire
Ramy czasowe: Baseline and at 4, 8, and 12 weeks
|
Baseline and at 4, 8, and 12 weeks
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Śledczy
- Główny śledczy: Heidi Donovan, Gynecologic Oncology Group
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- GOG-0259 (Inny identyfikator: CTEP)
- U10CA101165 (Grant/umowa NIH USA)
- NCI-2011-01950 (Identyfikator rejestru: CTRP (Clinical Trial Reporting Program))
- CDR0000648729
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Nawracający rak jajnika
-
Peking University Third HospitalJeszcze nie rekrutacjaRak jajnika | Platinum-sensitive Recurrent
-
Daryoush Hamidi Alamdari, PhDRejestracja na zaproszenieChoroba nieoperacyjna | Zaawansowany rak podstawnokomórkowy (BCC) | Morpheaform Basal Cell Carcinoma | Rak podstawnokomórkowy guzkowo-wrzodziejący | Infiltratywny rak podstawnokomórkowyIran
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)Jeszcze nie rekrutacjaSyndrom Lyncha | Dziedziczny zespół nowotworowy | BRCA1-Related Hereditary Breast and Ovarian Cancer Syndrome | BRCA2-Related Hereditary Breast and Ovarian Cancer SyndromeStany Zjednoczone
-
Taichung Veterans General HospitalZakończonyKardiotoksyczność | Rak płuca niedrobnokomórkowy (MeSH Term: Carcinoma, Non-Small-Cell Lung) | Działania niepożądane i reakcje niepożądane związane z lekami (Termin MeSH) | Inhibitor kinazy tyrozynowej EGFRTajwan
-
Michael A. O'DonnellRekrutacyjnyRak pęcherza | Rak urotelialny | BCG-niereagujący rak pęcherza moczowego | Nieinwazyjny rak pęcherza moczowego (NMIBC) | Carcinoma in Situ (CIS) | Wysokiej klasy guzy brodawczakowate pęcherza moczowego | Rak pęcherza moczowego w stadium Ta | Rak pęcherza moczowego w stadium T1 | Rak pęcherza moczowego oporny... i inne warunkiStany Zjednoczone
-
Fondazione del Piemonte per l'OncologiaRekrutacyjnyRak piersi | Rak jajnika | Rak jelita grubego | Czerniak (rak skóry) | Rak płuca niedrobnokomórkowy (MeSH Term: Carcinoma, Non-Small-Cell Lung)Włochy
Badania kliniczne na Ocena jakości życia
-
Memorial Sloan Kettering Cancer CenterZakończonyRodziny lub najbliżsi krewni pacjentów leczonych w MSKCC z powodu nieskórnego raka płaskonabłonkowego | Górny przewód pokarmowyStany Zjednoczone
-
The Hospital for Sick ChildrenUniversity of Pittsburgh; Childhood Arthritis and Rheumatology Research Alliance i inni współpracownicyRejestracja na zaproszenie
-
University Hospital, MontpellierPediatric and Congenital Cardiology Department of Necker-enfant malades University...ZakończonyWrodzona wada sercaFrancja
-
Antonella CostantinoIRCCS Eugenio Medea; Azienda Socio Sanitaria Territoriale della Valle OlonaRekrutacyjnyZaburzenia ze spektrum autyzmuWłochy
-
Avicenna Military HospitalZakończonyRekonwalescencja pooperacyjnaMaroko
-
Massachusetts General HospitalMedically HomeZakończony
-
Morehouse School of MedicineNational Institute on Minority Health and Health Disparities (NIMHD)RekrutacyjnyCukrzyca | Cukrzyca typu 2 | Przewlekła choroba | Siedzący tryb życia | Zdrowy tryb życia | Odżywianie, zdrowy | Rodzina | Badania rodziny | Rodzina i gospodarstwo domoweStany Zjednoczone
-
Lehigh UniversityNational Institute on Drug Abuse (NIDA); University of Kansas Medical CenterAktywny, nie rekrutujący
-
University of MiamiRekrutacyjnyDysfagiaStany Zjednoczone